YU45822B - Postupak za dobijanje supstituisanih etandimidamida - Google Patents
Postupak za dobijanje supstituisanih etandimidamidaInfo
- Publication number
- YU45822B YU45822B YU102587A YU102587A YU45822B YU 45822 B YU45822 B YU 45822B YU 102587 A YU102587 A YU 102587A YU 102587 A YU102587 A YU 102587A YU 45822 B YU45822 B YU 45822B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- substituted
- etandimidamides
- integer
- hydrogen
- values
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
POSTUPAK ZA DOBIJANJE SUPSTITUISANIH ETANDIMIDAMIDA, formule: u kojoj je R1 vodonik ili C1-4 alkil pravog ili račvastog niza; m je ceo broj sa vrednostima 0 ili 1; n je ceo broj sa vrednostima 2 ili 3; Z je sumpor, kiseonik ili metilen; i A je tiazolov ili pirimidinski prsten koji je supstituisan grupom: u kojoj je R5 vodonik ili C1-4 alkil grupa pavog ili račvastog niza, po potrebi supstituisana sa jednim ili više atoma halogena kao što su fluor, hlor ili brom, pod uslovom da halogeni supstituent nije prisutan na ugljenikovom atomu direktno vezanom za atom azota; i njihovih netoksičnih farmaceutski prihvatljivih soli, naznačen time, što obuhvata tretiranje jedinjenja formule: u kojoj su R1, m, n, Z i A kao što je definisano gore, sa jakom mineralnom kiselinom, kao što je HCl, u inertnom rastvaraču kao što je metanol i na temperaturi oko sobne, nakon čega se dobijeni proizvod izoluje u obliku svoje adicione soli sa kiselinom.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU102587A YU45822B (sh) | 1984-06-22 | 1987-06-03 | Postupak za dobijanje supstituisanih etandimidamida |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/623,588 US4644006A (en) | 1984-06-22 | 1984-06-22 | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
YU105185A YU45725B (sh) | 1984-06-22 | 1985-06-24 | Postupak za dobijanje supstituisanih 3,4-diamino-1,2,5-triadiazola |
YU102587A YU45822B (sh) | 1984-06-22 | 1987-06-03 | Postupak za dobijanje supstituisanih etandimidamida |
Publications (2)
Publication Number | Publication Date |
---|---|
YU102587A YU102587A (en) | 1988-02-29 |
YU45822B true YU45822B (sh) | 1992-07-20 |
Family
ID=24498651
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU105185A YU45725B (sh) | 1984-06-22 | 1985-06-24 | Postupak za dobijanje supstituisanih 3,4-diamino-1,2,5-triadiazola |
YU102587A YU45822B (sh) | 1984-06-22 | 1987-06-03 | Postupak za dobijanje supstituisanih etandimidamida |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU105185A YU45725B (sh) | 1984-06-22 | 1985-06-24 | Postupak za dobijanje supstituisanih 3,4-diamino-1,2,5-triadiazola |
Country Status (33)
Country | Link |
---|---|
US (1) | US4644006A (sh) |
JP (2) | JPS6118775A (sh) |
KR (1) | KR900004321B1 (sh) |
AR (1) | AR240935A1 (sh) |
AT (1) | AT390790B (sh) |
AU (2) | AU580605B2 (sh) |
BE (1) | BE902724A (sh) |
CA (2) | CA1267412A (sh) |
CH (1) | CH665210A5 (sh) |
CS (1) | CS257276B2 (sh) |
DD (1) | DD240889A5 (sh) |
DE (1) | DE3522101A1 (sh) |
DK (1) | DK282885A (sh) |
ES (2) | ES8702902A1 (sh) |
FI (1) | FI852405L (sh) |
FR (1) | FR2566406B1 (sh) |
GB (2) | GB2161157B (sh) |
GR (1) | GR851514B (sh) |
HU (1) | HU193992B (sh) |
IE (2) | IE58261B1 (sh) |
IL (1) | IL75567A0 (sh) |
IT (1) | IT1190372B (sh) |
LU (1) | LU85969A1 (sh) |
NL (1) | NL8501766A (sh) |
NO (1) | NO161856C (sh) |
NZ (1) | NZ212403A (sh) |
OA (1) | OA08039A (sh) |
PT (1) | PT80684B (sh) |
SE (1) | SE464305B (sh) |
SU (1) | SU1537136A3 (sh) |
YU (2) | YU45725B (sh) |
ZA (1) | ZA854710B (sh) |
ZW (1) | ZW10385A1 (sh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0535227A4 (en) * | 1990-05-29 | 1993-08-18 | Nippon Soda Co., Ltd. | N-substituted heterocyclic amidine derivative |
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657237A (en) * | 1968-05-22 | 1972-04-18 | Frosst & Co Charles E | Process for making 1 2 5-thiadiazoles in the sinister configuration |
NL189197C (nl) * | 1979-09-04 | 1993-02-01 | Bristol Myers Squibb Co | 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten. |
DE3175201D1 (en) * | 1980-04-30 | 1986-10-02 | Merck & Co Inc | Aminothiadiazoles as gastric secretion inhibitors |
US4394508A (en) * | 1980-06-07 | 1983-07-19 | Bristol-Myers Company | Chemical compounds |
EP0045155B1 (en) * | 1980-07-30 | 1985-01-02 | Imperial Chemical Industries Plc | Guanidine derivatives |
EP0060730A3 (en) * | 1981-03-18 | 1982-12-08 | Imperial Chemical Industries Plc | Bicyclic derivatives |
EP0065823A1 (en) * | 1981-05-13 | 1982-12-01 | Imperial Chemical Industries Plc | Heterocyclic guanidines as histamine H-2 antagonists |
US4528375A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
US4517366A (en) * | 1982-03-29 | 1985-05-14 | Bristol-Myers Company | Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles |
US4588826A (en) * | 1982-03-29 | 1986-05-13 | Bristol-Myers Company | Ethanediimidamide intermediates |
US4528377A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
NL8301063A (nl) * | 1982-03-29 | 1983-10-17 | Bristol Myers Co | Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden. |
US4528378A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
FI832519L (fi) * | 1982-07-12 | 1984-01-13 | Bristol Myers Co | Farmaceutiska foerfaranden och sammansaettningar |
US4520025A (en) * | 1982-07-21 | 1985-05-28 | William H. Rorer, Inc. | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
JPS5978171A (ja) * | 1982-10-26 | 1984-05-04 | Ikeda Mohandou:Kk | 複素環式化合物 |
US4440933A (en) * | 1983-03-16 | 1984-04-03 | Bristol-Myers Company | Process for preparing 1,2,5-thiadiazoles |
-
1984
- 1984-06-22 US US06/623,588 patent/US4644006A/en not_active Expired - Fee Related
-
1985
- 1985-06-05 SU SU853906050A patent/SU1537136A3/ru active
- 1985-06-07 CA CA000483419A patent/CA1267412A/en not_active Expired - Lifetime
- 1985-06-07 FR FR8508668A patent/FR2566406B1/fr not_active Expired
- 1985-06-12 CS CS854247A patent/CS257276B2/cs unknown
- 1985-06-13 NZ NZ212403A patent/NZ212403A/xx unknown
- 1985-06-17 FI FI852405A patent/FI852405L/fi not_active Application Discontinuation
- 1985-06-19 NL NL8501766A patent/NL8501766A/nl not_active Application Discontinuation
- 1985-06-19 DD DD85277533A patent/DD240889A5/de not_active IP Right Cessation
- 1985-06-19 AR AR300752A patent/AR240935A1/es active
- 1985-06-19 IL IL75567A patent/IL75567A0/xx not_active IP Right Cessation
- 1985-06-20 IT IT21217/85A patent/IT1190372B/it active
- 1985-06-20 SE SE8503110A patent/SE464305B/sv not_active IP Right Cessation
- 1985-06-20 GR GR851514A patent/GR851514B/el unknown
- 1985-06-20 DE DE19853522101 patent/DE3522101A1/de not_active Withdrawn
- 1985-06-20 KR KR1019850004457A patent/KR900004321B1/ko not_active IP Right Cessation
- 1985-06-21 IE IE155785A patent/IE58261B1/en not_active IP Right Cessation
- 1985-06-21 BE BE0/215242A patent/BE902724A/fr not_active IP Right Cessation
- 1985-06-21 LU LU85969A patent/LU85969A1/fr unknown
- 1985-06-21 AU AU43920/85A patent/AU580605B2/en not_active Ceased
- 1985-06-21 HU HU852443A patent/HU193992B/hu not_active IP Right Cessation
- 1985-06-21 ZA ZA854710A patent/ZA854710B/xx unknown
- 1985-06-21 NO NO852519A patent/NO161856C/no unknown
- 1985-06-21 PT PT80684A patent/PT80684B/pt not_active IP Right Cessation
- 1985-06-21 AT AT0185885A patent/AT390790B/de not_active IP Right Cessation
- 1985-06-21 JP JP60135861A patent/JPS6118775A/ja active Pending
- 1985-06-21 ES ES544409A patent/ES8702902A1/es not_active Expired
- 1985-06-21 CH CH2657/85A patent/CH665210A5/de not_active IP Right Cessation
- 1985-06-21 IE IE501/89A patent/IE57937B1/en not_active IP Right Cessation
- 1985-06-21 GB GB08515749A patent/GB2161157B/en not_active Expired
- 1985-06-21 DK DK282885A patent/DK282885A/da unknown
- 1985-06-21 ZW ZW103/85A patent/ZW10385A1/xx unknown
- 1985-06-24 YU YU105185A patent/YU45725B/sh unknown
- 1985-08-18 OA OA58614A patent/OA08039A/xx unknown
- 1985-10-04 JP JP60221721A patent/JPS61186369A/ja active Pending
-
1986
- 1986-01-31 ES ES551506A patent/ES8702881A1/es not_active Expired
-
1987
- 1987-06-03 YU YU102587A patent/YU45822B/sh unknown
- 1987-07-09 GB GB08716149A patent/GB2192884B/en not_active Expired
-
1989
- 1989-02-08 AU AU29775/89A patent/AU614331B2/en not_active Ceased
- 1989-05-12 CA CA000599622A patent/CA1297875C/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920701207A (ko) | 신규 키산틴 유도체 | |
NZ210228A (en) | 1h-imidazo (4,5-c quinoline derivatives and bronchodilatory and antiviral compositions containing such | |
DK157861C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf | |
ES8203845A1 (es) | Procedimiento para preparar derivados de piridoxina | |
ES8801273A1 (es) | Un procedimiento para la preparacion de nuevos derivados de purina | |
IL58256A (en) | N-pyrrolyl-pyridazineamines,process for their manufacture and antihypertensive compositions containing them | |
ES8802040A1 (es) | Un procedimiento para la preparacion de fenialquil-2,3-dihidrobenzofuranos y los correspondientes dihidrobenzopiranos | |
YU45822B (sh) | Postupak za dobijanje supstituisanih etandimidamida | |
ES477756A1 (es) | Procedimiento para preparar composiciones herbicidas. | |
ES8301219A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas | |
HRP20000027B1 (en) | Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds | |
IE41409L (en) | 3-piperazino-isoquinoline derivatives | |
ZA793108B (en) | Imidazo (1,2-a) imidazole derivatives,processes for their preparation,compositions thereof | |
KR830008484A (ko) | 제초 조성물 | |
ES8303446A1 (es) | Procedimiento para la obtencion de derivados de aminoacridin (d) y (l)-n-glicosido. | |
DE3367209D1 (en) | Aminoethoxybenzylalcohol derivatives, process for their preparation and pharmaceutical compositions containing them | |
ZA807790B (en) | 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof | |
ES433593A1 (es) | Un procedimiento para preparar derivados del 1, 4-dioxido dequinoxalin-2-carboxamida. | |
DE3367392D1 (en) | Dioxanylazol derivatives, fungicides containing them and their use as fungicides | |
DE3060406D1 (en) | Antimycotic agent, process for its preparation | |
ES8200661A1 (es) | Un procedimiento para la preparacion de nuevos derivados de dihidropiridina | |
YU182991A (sh) | Hemijski postupak za dobijanje novih 3-h-purina | |
GB1410162A (en) | 2-aminoindane derivatives | |
ES265955A1 (es) | Procedimiento de obtenciën de derivados de 1-azatiaxanteno | |
GB951653A (en) | Improvements in or relating to 6-pteridinehydrazide and amidrazone derivatives |